Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $276.7M | $296.0M | $274.6M | $231.1M | $178.3M | $190.2M | $346.9M | $373.1M |
| Cost of revenue | $155.7M | $157.7M | $142.1M | $110.1M | $74.3M | $81.8M | $161.9M | $166.5M |
| Gross profit | $121.0M | $138.3M | $132.6M | $121.0M | $103.9M | $108.3M | $185.0M | $206.5M |
| Gross margin | 43.7% | 46.7% | 48.3% | 52.3% | 58.3% | 57.0% | 53.3% | 55.4% |
| R&D | $14.1M | $11.6M | $5.9M | $6.6M | $3.5M | $18.4M | $43.5M | $39.4M |
| Operating income | −$13.9M | $1.6M | $4.9M | −$9.1M | $14.2M | $1.1M | $7.2M | $18.1M |
| EBITDA | −$5.8M | $14.0M | $25.9M | $23.1M | $21.9M | $31.4M | $29.4M | $61.2M |
| Net income | −$16.1M | −$1.9M | $20.9M | −$5.8M | $46.2M | −$8.1M | $15.9M | −$3.6M |
| Net margin | -5.8% | -0.6% | 7.6% | -2.5% | 25.9% | -4.3% | 4.6% | -1.0% |
| EPS (diluted) | -1.19 | -0.14 | 1.55 | -0.43 | 2.68 | -0.53 | 0.99 | -0.21 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $531M | $1.80 | $1.59–$1.90 | 1 |
| 2027 | $610M | $2.50 | $2.21–$2.64 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds GGRGF.
No tracked institution reports a position in GGRGF as of their last filing.
No one on the platform has traded GGRGF yet.
| $736M |
| — |
| HIZOFKanadevia Corp | $7.70 | +0.00% | $1.3B | — |
| MIESFMitsui E&S Holdings Co., Ltd. | $35.31 | +0.00% | $3.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.3× sales vs its 0.9× historical median P/S.
Fair value ≈ $21.28 · price $51.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.